Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)

NCT00481455 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Glioblastoma Multiforme

Interventions

DRUG: Panzem NCD
DRUG: Temozolomide

Sponsor

CASI pharmaceuticals, Inc.